date,title,source
Oct-18-18,Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients Perspective,GlobeNewswire
Oct-23-18,"Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study",GlobeNewswire
